Picture of Omnicell logo

OMCL Omnicell Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapContrarian

Annual cashflow statement for Omnicell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line61.332.277.85.65-20.4
Depreciation
Deferred Taxes
Non-Cash Items47.361.987.69681.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital-15.837.3-3.34-73.543.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities14518623277.8181
Capital Expenditures-61.7-54.9-58.3-60.7-55
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items0-225-3542.070
Acquisition of Business
Other Investing Cash Flow
Cash from Investing Activities-61.7-280-412-58.7-55
Financing Cash Flow Items-12-5.3-20-8.933.17
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-23.545647.4-2123.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash60363-134-2.79148